Johnson & Johnson (ETR:JNJ)

Market Cap	395.15B
Revenue (ttm)	77.35B
Net Income (ttm)	19.34B
Shares Out	n/a
EPS (ttm)	7.97
PE Ratio	20.43
Forward PE	17.45
Dividend	4.62 (2.80%)
Ex-Dividend Date	Aug 26, 2025

Volume	5,736
Average Volume	4,104
Open	164.92
Previous Close	165.00
Day's Range	164.30 - 165.88
52-Week Range	128.16 - 165.88
Beta	0.39
RSI	83.45
Earnings Date	Oct 14, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD